Viewing StudyNCT04401761



Ignite Creation Date: 2024-05-06 @ 2:44 PM
Last Modification Date: 2024-10-26 @ 1:36 PM
Study NCT ID: NCT04401761
Status: COMPLETED
Last Update Posted: 2023-10-25
First Post: 2020-05-22

Brief Title: A Study to Collect Data on the Treatment Pattern of Xarelto Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and or a Condition That Most Commonly Narrows the Blood Vessel in the Legs
Sponsor:
Organization: Bayer

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 3189
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
65357
Who Masked List: